Richard Ruedy

Ric Ruedy joined Silk Road in 2011 and is the Executive Vice President of Clinical and Regulatory Affairs, and Quality Assurance. Ric brings to Silk Road Medical 25 years of experience in the Regulatory, Clinical and Quality areas for both multi-national corporations and venture- backed start-ups. Prior to Silk Road Medical, Ric served as Vice President of Regulatory, Clinical and Quality for Nevro Corporation and, earlier, at Cardica, Inc. Ric also served as Director of Regulatory Affairs at Abbott Vascular, where he obtained the second carotid stent approval in the United States. Ric is a co-founder of Acta Vascular (acquired by Covidien) and held positions of increasing responsibility at Edwards Lifescienses, Medtronic, TriPath Imaging (acquired by Becton Dickinson), and Parallax Medical (acquired by Arthrocare). Ric has a B.A. in English and International Relations from Bucknell University.